Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
Wall Street is generally afraid of uncertainty, but with adversity also comes opportunity. Find out my 2 picks that have well-above average yields.
12d
Zacks Investment Research on MSNMerck (MRK) Up 3.9% Since Last Earnings Report: Can It Continue?A month has gone by since the last earnings report for Merck (MRK). Shares have added about 3.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...
A recent CNN report cast a spotlight on Akeso, a Chinese biotech company whose immunotherapy ivonescimab drug, now in ...
WASHINGTON-President Trump put his disruptive return to power on full display during a prime-time address to Congress, offering a no-apologies assessment of his decisions to crack down on illegal ...
While its renewed product mix is anticipated to negatively impact ... rapidly approaching commercialization, the company’s early-stage pipeline is less promising. Management has repeatedly ...
These well-known U.S. companies provide a mix of investments across ... bank and financial services holding company, which provides various financial products and services for individual consumers ...
For some products, this results in supply chains that ... drugs to market and alerting them to any delays that might occur. Mix ups in hand-offs are another large disruptor, especially when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results